Results 151 to 160 of about 13,488 (162)

Biotransformation of cadinane sesquiterpenes by Beauveria bassiana ATCC 7159

Phytochemistry, 2000
Lawrence A D Williams, Paul B Reese
exaly  

Biotransformation of diterpenes and diterpene derivatives by Beauveria bassiana ATCC 7159

Phytochemistry, 2001
Paul B Reese
exaly  

A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)

Investigational New Drugs, 2008
Sharlene Gill, Timothy W Synold, Pierre Major   +2 more
exaly  

Chiral auxiliaries as docking/protecting groups: biohydroxylation of selected ketones with Beauveria bassiana ATCC 7159

Tetrahedron, 2001
Anna De Raadt, Robert Saf
exaly  

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors

Frontiers in Cell and Developmental Biology, 2020
Qingyang Lei, Kai Sun, Liping Wang
exaly  

Resistance to PD1/PDL1 checkpoint inhibition

Cancer Treatment Reviews, 2017
Jake S O'Donnell, Georgina V Long, Richard A Scolyer   +2 more
exaly  

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Annals of Oncology, 2017
Georgina V Long, Serigne Lo, Alexander M Menzies   +2 more
exaly  

Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma

Journal of Bone Oncology, 2020
Junlong Wu, Junlong Wu
exaly  

The diverse functions of the PD1 inhibitory pathway

Nature Reviews Immunology, 2017
Arlene H Sharpe, Kristen E Pauken, Sharpe Arlene H   +2 more
exaly  

Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients

OncoImmunology, 2018
Xiaofang Xing, Wenyi Wei, Guangyu Ding   +2 more
exaly